Stem Cell Therapy for Autism

Yes. Numerous international studies have demonstrated the safety of mesenchymal stem cell (MSC) therapy.
At Stem Cell in Turkey, we use MSCs derived from umbilical cord and placental tissue—which are collected in sterile, ethically approved laboratories and tested extensively before use.

Why it’s safe:

• MSCs are naturally immunomodulatory, meaning they reduce inflammation and prevent tissue rejection.

• They lack MHC Class II molecules, minimizing the risk of immune reactions.

• Every batch of stem cells undergoes purity, viability, and sterility testing, including bacterial, fungal, viral, and genetic screening.

• Dosages are personalized; exceeding the safe limit could lead to complications such as vascular overload, so every patient receives a carefully calculated dose.

A standard treatment program lasts between 3 and 9 days, with one injection per day and complementary non-invasive sessions (like inhalations).
Patients can repeat the therapy after 6 months if desired, to strengthen or extend the improvements achieved.

We use umbilical cord and placental-derived mesenchymal stem cells, delivered primarily via intravenous and intramuscular injections.
Mild sedation may be provided to ensure comfort. In some cases, exosome inhalation therapy is added to enhance neuroregenerative effects.

The dosage depends on the child’s body weight and treatment route. For safety, we generally administer no more than 3 million cells per kilogram via intravenous infusion, always under strict medical supervision.

Stem cell therapy is not a cure for autism, but it can lead to meaningful, measurable improvement.
Around 80% of our patients show noticeable progress in areas such as:

• Improved eye contact and attention

• Better verbal and non-verbal communication

• Stronger emotional connection with parents and peers

• Increased focus and reduced repetitive behaviors

• Better appetite and digestive balance

The results vary depending on the child’s age, overall health, and the severity of ASD.

Side effects are rare and mild—such as temporary fatigue, low-grade fever, or mild nausea, typically resolving within hours.
Only about 5% of patients experience such temporary symptoms.
There are no lasting side effects associated with MSC therapy.

While technically possible, it is not generally recommended.
Parent-derived cells take about a month to prepare and may be less effective if autism has a genetic component.
Umbilical cord and placental stem cells, on the other hand, are younger, more active, and available immediately—making them a safer and more effective option.

No. The stem cells we use are adult mesenchymal stem cells, not embryonic or fetal cells.
These cells have a stable genetic structure and do not multiply uncontrollably.
Before use, every batch undergoes rigorous molecular testing to rule out mutations.
However, if a patient already has cancer, stem cell therapy is not recommended, since it may stimulate existing tumor cells.

Approximately 80% of children show observable improvement after therapy.
However, the degree of change varies by individual and depends on factors such as age, developmental stage, and early intervention.

Our medical team is trained specifically to work with children with ASD.

• Child-friendly environment: Rooms are designed to feel homelike rather than clinical.

• Trained professionals: Nurses and doctors communicate in a gentle, reassuring way.

• Parent presence: Parents are always allowed during procedures.

• Mild sedation: Used only when necessary to reduce anxiety and ensure comfort.

For the standard ASD program, children should be over 3 years old and weigh at least 15 kg.
We also offer a “light program” for developmental delays starting from 1 year of age.

While most patients are children, adults can also receive treatment.
In some cases, therapy has helped adults with ASD improve social adaptation and reduce ADHD-related symptoms, though the outcomes are typically more modest.

Stem cell therapy is not recommended for:

• Children under 1 year old

• Patients with a history of cancer

• Certain forms of severe epilepsy

All candidates are evaluated individually by our medical team before admission.

The most frequent outcomes reported by families include:

• Better communication and understanding

• Improved social interaction and focus

• Greater independence in hygiene and daily routines

• Calmer behavior and reduced aggression

• Fewer digestive issues and better appetite

At Stem Cell in Turkey, we ensure that both children and parents feel comfortable during their stay.

• We offer customized meal plans prepared by our in-house kitchen.

• There are play areas for children and rest areas for families.

• Speech and occupational therapy are available upon request to support post-treatment development.